Intersphincteric resection for low rectal cancer: the risk is functional rather than oncological. A 25-year experience from Bordeaux.
Rectal cancer
distal resection margin
faecal incontinence
intersphincteric resection
radiotherapy
sphincter preservation
Journal
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
13
09
2019
accepted:
03
04
2020
pubmed:
11
7
2020
medline:
19
8
2021
entrez:
11
7
2020
Statut:
ppublish
Résumé
There are few data evaluating the long-term outcomes of intersphincteric resection (ISR), especially the impact of inclusion of more juxtapositioned and intra-anal tumours on oncological and functional outcomes. We compared the oncological and functional results of patients treated by total mesorectal excision and ISR for low rectal cancer over a 25-year period. This is a retrospective study from a single institution evaluating results of ISR over three periods: 1990-1998, 1999-2006 and 2007-2014. Patients treated by partial or total ISR, with or without neoadjuvant chemoradiotherapy, for low rectal cancer (≤ 6 cm from the anal verge) were included. We compared postoperative morbidity, quality of surgery and oncological and functional outcomes in the time periods studied. Of 813 patients operated on for low rectal cancer, 303 had ISR. Tumour stage did not differ; however, the distance of the tumour from the anorectal junction decreased from 1 to 0 cm (P < 0.001) and the distal resection margin shortened from 25 to 10 mm (P < 0.001) from 1990 to 2014. The postoperative morbidity and quality of surgery did not change significantly over time. The 5-year local recurrence (4.3% vs 5.9% vs 3.5%; P = 0.741) and disease-free survival (72% vs 71% vs 75%; P = 0.918) did not differ between the three time periods. Functional results improved during the last period; however, overall 42% of patients experienced major bowel dysfunction. Pushing the envelope of sphincter-saving resection in ultra-low rectal cancer reaching or invading the anal sphincter did not compromise oncological and functional outcomes. The main limitation of the ISR procedure appears to be functional rather than oncological, suggesting that bowel rehabilitation programmes should be developed.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1603-1613Informations de copyright
© 2020 The Association of Coloproctology of Great Britain and Ireland.
Références
Heald RJ, Moran BJ, Ryall RD et al. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133: 894-9.
Mulsow J, Winter DC. Sphincter preservation for distal rectal cancer - a goal worth achieving at all costs? World J Gastroenterol 2011; 17: 855-61.
Williams NS, Dixon MF, Johnston D. Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients survival. Br J Surg 1983; 70: 150-4.
Ueno H, Mochizuki H, Hashiguchi Y et al. Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer. Ann Surg 2004; 239: 34-42.
Schiessel R, Karner-Hanusch J, Herbst F, Teleky B, Wunderlich M. Intersphincteric resection for low rectal tumours. Br J Surg 1994; 81: 1376-8.
Rullier E, Zerbib F, Laurent C et al. Intersphincteric resection with excision of internal anal sphincter for conservative treatment of very low rectal cancer. Dis Colon Rectum 1999; 42: 1168-75.
Rullier E, Laurent C, Bretagnol F et al. Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule. Ann Surg 2005; 241: 465-9.
Denost Q, Adam JP, Rullier A et al. Perineal Transanal approach: a new standard for laparoscopic sphincter-saving resection in low rectal cancer, a randomized trial. Ann Surg 2014; 260: 993-9.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-13.
Denost Q, Rouanet P, Faucheron JL et al. To drain or not to drain infra-peritoneal anastomosis after rectal excision for cancer: the GRECCAR 5 randomized trial. Ann Surg 2017; 265: 474-80.
Washington MK, Berlin J, Branton P et al. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med 2009; 133: 1539-51.
Nagtegaal ID, van de Veld CJ, van der Worp E et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002; 20: 1729-34.
Emmertsen KJ, Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg 2012; 255: 922-8.
Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum 1993; 36: 77-96.
Denost Q, Laurent C, Capdepont M et al. Risk factors for fecal incontinence after intersphincteric resection for rectal cancer. Dis Colon Rectum 2011; 54: 963-8.
Saito N, Ono M, Sugito M et al. Early results of intersphincteric resection for patients with very low rectal cancer: an active approach to avoid a permanent colostomy. Dis Colon Rectum 2004; 47: 459-66.
Tiret E, Poupardin B, McNamara D et al. Ultralow anterior resection with intersphincteric dissection-what is the limit of safe sphincter preservation? Colorectal Dis 2003; 5: 454-7.
Vorobiev GI, Odaryuk TS, Tsarkov PV et al. Resection of the rectum and total excision of the internal anal sphincter with smooth muscle plasty and colonic pouch for treatment of ultralow rectal carcinoma. Br J Surg 2004; 91: 1506-12.
Birbeck KF, Macklin CP, Tiffin N et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002; 235: 449-57.
Köhler A, Athanasiadis S, Ommer A et al. Long term results of low anterior resection with intersphincteric anstomosis in carcinoma of the lower one-third of the rectum: analysis of 31 patients. Dis Colon Rectum 2000; 43: 843-50.
Akasu T, Takawa M, Yamamoto S et al. Incidence and patterns of recurrence after intersphincteric resection for very low rectal adenocarcinoma. J Am Coll Surg 2007; 205: 642-7.
Marks G, Mohiuddin M, Eitan A et al. High-dose preoperative radiation and radical sphincter-preserving surgery for rectal cancer. Arch Surg 1991; 126: 1534-40.
Wagman R, Minsky BD, Cohen AM et al. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. Int J Radiat Oncol Biol Phys 1998; 42: 51-7.
Janjan NA, Khoo VS, Abbruzzese J et al. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 1999; 44: 1027-38.
Rullier E, Goffre B, Bonnel C et al. Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg 2001; 234: 633-40.
Rouanet P, Saint-Aubert B, Lemanski C et al. Restorative and nonrestorative surgery for low rectal cancer after high-dose radiation: long-term oncologic and functional results. Dis Colon Rectum 2002; 45: 305-13.
Gerard JP, Chapet O, Nemoz C et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial. J Clin Oncol 2004; 22: 2404-9.
Weiser MR, Quah HM, Shia J et al. Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection. Ann Surg 2009; 249: 236-42.
Rullier E, Denost Q, Vendrely V, Rullier A, Laurent C. Low rectal cancer: classification and standardization of surgery. Dis Colon Rectum 2013; 56: 560-7.
Shirouzu K, Murakami N, Akagi Y. Intersphincteric resection for very low rectal cancer: a review of the updated literature. Ann Gastroenterol Surg 2017; 1: 24-32.
Garcia-Aguilar J, Chow S, Smith DD et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol 2015; 16: 957-66.
Wrenn SM, Cepeda-Benito A, Ramos-Valadez DI, Cataldo PA. Patient perceptions and quality of life after colon and rectal surgery: what do patients really want? Dis Colon Rectum 2018; 61: 971-8.
Gamagami R, Itvan G, Cabarrot P et al. Fecal continence following partial resection of the anal canal in distal rectal cancer: long term results after coloanal anastomoses. Surgery 2000; 127: 291-5.
Bittorf B, Stadelmaier U, Göhl J et al. Functional outcome after intersphincteric resection of the rectum with coloanal anastomosis in low rectal cancer. Eur J Surg Oncol 2004; 30: 260-5.
Chamlou P, Parc Y, Simon T et al. Long-term results of intersphincteric resection for low rectal cancer. Ann Surg 2007; 246: 916-22.
Grumann MM, Noack EM, Hoffmann IA et al. Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg 2001; 233: 149-56.
Celerier B, Denost Q, van Geluwe B et al. The risk of definitive stoma formation at 10 years after low and ultralow anterior resection for rectal cancer. Colorectal Dis 2016; 18: 59-66.
Didailler R, Denost Q, Loughlin P et al. Antegrade enema after TME for rectal cancer: the last chance to avoid definitive colostomy for refractory LARS and fecal incontinence. Dis Colon Rectum 2018; 61: 667-72.